Use a specialist medicines resource when the question requires detailed drug information, interaction evidence, compatibility or toxicology. Use a broader clinical reference when the main need is understanding the surrounding condition or reasoning. UpToDate Lexidrug, Micromedex and iatroX overlap at the edges, but they should not be treated as interchangeable databases.
This comparison is published by iatroX and includes iatroX. It updates the earlier Lexicomp-versus-Micromedex framing using public information checked on 20 September 2026, rather than a new authenticated usability trial.
Lexicomp is now UpToDate Lexidrug
The current UpToDate Lexidrug product is the relevant destination for readers searching the historical Lexicomp name. Check the actual database package and access route, particularly where an employer supplies several related Wolters Kluwer products. A link from a clinical topic is not proof that every specialist module is included.
As published on 20 September 2026, Micromedex includes medicines information and specialist resources across medication management and toxicology, and advertises AI-powered search. An old description of Micromedex as an unchanged interface competing with modern AI is no longer an adequate comparison.
Public product scope can identify candidates for a shortlist. It cannot establish that one interface is universally faster, that one database contains every obscure answer, or that a reader's institution has licensed every resource mentioned by the supplier.
Classify the question before opening the database
"Can this medicine be used?" can conceal several different questions. The clinician may need to check a contraindication, investigate an interaction, understand a formulation, clarify administration or review the condition being treated. The first useful action is to state which of these is unresolved.
For a routine monograph lookup, inspect the exact medicine and relevant section. For an interaction, identify both substances and the actual clinical question. For an administration query, specify the product and conditions rather than assume that information about one formulation applies to another. For a broader learning question, ask what concept is unclear before demanding a patient-specific conclusion.
This classification also improves a request to a pharmacist or medicines-information service. A bounded question exposes missing facts and makes it easier to see when specialist advice, rather than more searching, is needed.
Four tasks for a fair comparison
| Task | What an adequate resource needs to expose | What should not be inferred |
|---|---|---|
| Clinical verification | The relevant monograph and its qualification | A short summary covers every exception |
| Interaction review | Evidence, mechanism and clinical relevance | A warning alone determines the patient's plan |
| Administration or compatibility | The exact conditions addressed by the specialist source | No result means compatibility |
| Toxicology enquiry | Appropriate specialist information and escalation arrangements | A general drug summary replaces urgent expert advice |
The table is an original evaluation framework. It does not award a winner because the public pages do not establish task-level comparative performance. In particular, the previous shorthand of "Lexicomp for usability, Micromedex for everything difficult" hides variation in entitlements, questions and user needs.
Work through an original medicines enquiry
A fictional ward team wants to understand why a medicine appears on two documents with different formulation descriptions. The team also asks whether the planned administration arrangement is appropriate. Those are two questions, not one.
First establish the actual prescribed and supplied products through the clinical record and pharmacy process. A database cannot settle a documentary discrepancy by guessing which entry is current. Then consult the relevant product information and specialist administration resource for the precise question. Finally, record the unresolved point and who will confirm it.
A general explanation of how formulations can differ may help a learner understand why the discrepancy matters. It does not authorise substitution. This is an example of the point at which iatroX can support understanding while a specialist reference and the responsible team remain necessary for the operational decision.
Do not lose the important specialist distinctions
Paediatric information, interaction analysis, injectable compatibility and poison information deserve separate checks. Their presence somewhere in a product family does not mean every individual subscription contains them. Ask the library to identify the exact resources available and use the supplier's current documentation for the package.
In an overdose or poisoning enquiry, the appropriate local emergency and poisons-information routes matter as well as the database. A comparative article should not encourage a clinician to delay necessary assessment while shopping between subscriptions. Toxicology depth is a legitimate purchasing criterion; a marketing adjective is not a substitute for checking access and intended use.
Similarly, medicines verification may depend on national product information and local policy. A US-oriented monograph can be useful background without settling the authorised formulation or arrangements in another jurisdiction. Preserve the distinction between transferable pharmacology and a country-specific product decision.
What AI-powered search changes
A conversational query may make a specialist collection easier to navigate. It does not remove the need to inspect the relevant monograph and the boundaries of the evidence. The comparison should ask whether the search retrieves the correct product, retains qualifying conditions and provides a usable route to the source.
An original test question could deliberately omit the formulation. A useful response should make the omission visible rather than silently complete it. Record the prompt, result, source and product version when running such an evaluation. No actual results from that test are claimed here.
Where iatroX adds a different kind of value
Ask-iatroX's September 2026 specification describes free clinical reference grounded in sources including NICE, CKS, SIGN and emc SmPC information. The medicines area provides an appropriate route into source-linked clinical understanding. That is not a claim of a licence to Lexidrug, Micromedex or every specialist database discussed in this article.
For a recurring pharmacology misconception, relevant question practice and Socratic Tutor can support further learning. The paid UK package, published on 20 September 2026, costs £99 upfront annually or £29 monthly and combines the learning tools rather than charging separately for simulations and CPD. It should be evaluated for that educational use, not priced as though it replaces a hospital medicines-information contract.
Choose by the unresolved task
Use the specialist resource available to you when it contains the precise information required. Compare packages before purchasing a missing specialist function. Use iatroX for suitable clarification and learning around the question. Where evidence is absent, conflicting or outside your expertise, formulate a focused request for the appropriate service rather than convert uncertainty into a confident generated answer.
Frequently asked questions
Is Lexicomp the same name as Lexidrug?
Lexicomp is the historical name readers may recognise; the current Wolters Kluwer product is UpToDate Lexidrug. Check the current package rather than relying on an old subscription description.
Does Micromedex now have AI search?
Yes, Merative advertises AI-powered search on its public Micromedex page as checked on 20 September 2026. Confirm availability within your own access arrangement.
Can iatroX replace a specialist interaction or compatibility database?
That equivalence is not established. It can support clinical explanation and learning, while specialist medicines questions still require the appropriate source and professional review.